Moderate neutropenia , moderate sensory neuropathy , and mild to moderate , reversible alopecia occurred only at doses of 70 and 100 mg/m ( 2 ) ; therefore , doses of 70 mg/m ( 2 ) or higher were considered unacceptable in this patient population .
